Varenzin-CA1 is a revolutionary new treatment in the fight against non-regenerative anemia in cats with CKD.
Today, Elanco Animal Health Incorporated (NYSE: ELAN) announced that the first shipments of Varenzin-CA1 (molidustat oral suspension)
Varenzin -CA1 (molidustat oral suspension) Canine Parvovirus mAb. Parasitology. Show submenu for
erythropoietin (EPO). Clipboard with writing on it superimposed by Buy Now Victor Medical Logo Buy Now. Varenzin-CA1 FAQs. What is the active
Federal law restricts this drug to use by or on the order of a licensed veterinarian. Description. Varenzin-CA1 (molidustat oral suspension) is a white to
The use of Varenzin-CA1 administered concurrently with other erythropoiesis-stimulating agents (ESAs), including recombinant human erythropoietin (rHuEPO) drugs, has not been studied. The decision regarding whether or not to transition a patient from other ESAs to Varenzin-CA1 is ultimately the responsibility of the prescribing veterinarian.
Varenzin-CA1 from Elanco is the first drug for the control of nonregenerative anemia associated with chronic kidney disease in cats to
Varenzin CA-1 Varenzin-CA1 25mg/mL Oral Suspension for Cats, 27mL bottle Gabapentin Compounded Tablet, 50-mg, 60 Tablets. 4 Counts
Varenzin -CA1 Oral Suspension is a once-daily oral option that safely treats non-regenerative anemia in cats with chronic kidney disease (CKD). Varenzin-CA1 Oral Suspension (Rx)
Comments